genomize

[genomize @genomize]

Thank you to everyone who joined us at #ESHG2023. Your questions and discussions not only enriched the event but helped us better understand your needs and aspirations.


Looking forward to seeing you again in Berlin for #ESHG2024!

#ngsdataanalysis #bioinformatics #ai

[genomize @genomize]

Thank you for your interest on Day 1 in our NGS data analysis software, the SEQ Platform!

📍 Visit our booth #244 to experience the new interface of the SEQ Platform and the Variant Prioritization feature. Looking forward to meeting you today!

#eshg2023 #bioinformatics

[genomize @genomize]

Automated ACMG classification of variants is different among different software. Pathogenic becomes VUS, and VUS becomes pathogenic. For a systematic comparison of algorithms with the Clingen truth set, visit our poster at P18.104.D Looking forward to discussing!

#eshg2023

[genomize @genomize]

Do you know that you can prioritize the causative variants with a 96.1% prioritization success rate by using the SEQ Platform?

That’s not all! You can also filter the variants by 90% more efficiently with the SEQ Platform’s superior data aggregation.

#eshg2023 #ngsdataanalysis

[genomize @genomize]

We are ready for #ESHG2023!

📍 We welcome all attendees to visit us at booth #244. Our team is excited to demonstrate how the SEQ Platform can serve as a valuable tool for NGS data analysis.

We look forward to your visit and meeting you.

#ngsdataanalysis #variantinterpretation

[genomize @genomize]

🙌 Just 1 month to go! We are thrilled about attending ESHG 2023 in Glasgow, June 10-14.

🧬 As a dynamic and fast-growing bioinformatics company, we can't wait to showcase our innovative solutions and connect with the brightest minds at #ESHG2023.

#humangenetics #bioinformatics

[genomize @genomize]

SEQ Platform v7.6 is now live! 🎉

🧬 Support for hg38 Genome Version

You can now align and annotate your samples using the hg38 genome version with the SEQ Platform.

To try our new features and learn more about the SEQ Platform 👇
https://t.co/KJWVKE4ZMN

#releasenotes #hg38

[genomize @genomize]

that increase diagnosis rates and improve patient outcomes.

We believe that ending rare diseases and raising diagnosis rates require collaboration from all of us!

You can learn more by following the link below;
https://t.co/uPFG4k1jZc

#rarediseases #rarediseaseawareness

[genomize @genomize]

Today is #RareDiseaseDay, and we want to take a moment to acknowledge people with rare diseases 👇

It's estimated that nearly 300 million people worldwide are affected by one of the 6,000+ different types of rare diseases.
.
.

[genomize @genomize]

Although 72% of rare diseases are inherited genetically, and 70% of these genetic diseases start in childhood, unfortunately, the diagnosis rate is still very low.

As Genomize, we’re committed to supporting individuals with rare diseases by developing innovative solutions
.
.

[genomize @genomize]

🎄🎉👀 2022 is right behind us! We worked with joy to bring you new features and improvements.

Thank you for being a valuable member of our community. Happy new year and keep following us for more exciting news in 2023!

Here are the highlights:

#wrapped #wrapped2022 #newyear

[genomize @genomize]

SEQ Platform v7.3 is now live! 🎉

👨‍👩‍👧 New Multi-Sample Analysis Interface

"Multi-Sample Analysis", one of the most appreciated and useful features of the SEQ Platform, now has a new interface.

To try our new features and learn more about SEQ Platform 👇
https://t.co/KJWVKEm2ON

[genomize @genomize]

Today, Svante Pääbo, a Swedish geneticist at the Max Planck Institute, has been awarded the 2022 Nobel Prize in Physiology or Medicine "for his discoveries concerning the genomes of extinct hominins and human evolution."

https://t.co/Rz0yoja4Dr

#NobelPrize2022 #NobelPrize

[genomize @genomize]

Today is World Lymphoma Awareness Day!

Do you know that lymphoma is the third most common cancer form in children?

Every year, thousands of children are diagnosed with lymphoma, all around the world.

#LymphomaAwareness #Awareness #Cancer #cancerawareness #care #treatment

[genomize @genomize]

📣 SEQ Platform v7.1.0 is now live!

Our new interface for the SEQ Platform's parameter-optimized GATK CNV analysis and new quick filter set feature are now live.

To try our new features and learn more about the SEQ Platform 👇
https://t.co/Dw4voq0WHB

#NGS #Bioinformatics

[genomize @genomize]

Although starting the NGS data analysis from VCF file seems attractive especially due to the ~20X data storage advantage, we believe FASTQ is the better starting point.

#bioinformatics #ngs #dataanalysis #fastq #vcf

[genomize @genomize]

Thank you for your interests in our NGS Data Analysis Platform SEQ and Consumer Genomics Toolkit!

We're looking forward to meet you today. Visit our Booth 774 | Hall X4 to learn more about our tools! @eshgsociety

#ESHG2022 #Bioinformatics #consumergenomics #Vienna

[genomize @genomize]

First day of #ESHG2022!

Meet with our team at Booth 774 | Hall X4!

@eshgsociety #ESHG2022 #consumergenomics #genetics

[genomize @genomize]

Last 3 days!

We are attending #ESHG2022 conference this weekend.

We are looking forward to hear about latest developments in Human Genetics and to tell you about our brand new consumer genomics product.

Visit us at our Booth 774 | Hall X4!

#genomics #consumergenomics #genetic

[genomize @genomize]

Join us at #ESHG2022!

To learn more about the SEQ Platform and our brand new Consumer Genomics Toolkit visit us at our Boot 774 in Hall X4.

Don’t forget to book a meeting;
https://t.co/waeZJi6uE9

@eshgsociety #eshg #genetics #consumergenomics

[European Society of Human Genetics (ESHG) @eshgsociety]

Download the ESHG app including the programme, speakers, floor plans, etc for #eshg2022 now. Interested in participating? Register for online or in-person participation today. #genetics #genomics https://t.co/x5lcO9GCGG